Sphera Funds Management Ltd
$691M 13F equity value
113 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Sphera Funds Management Ltd covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,500,082 | $51M | 7.4% |
| MLYS | MINERALYS THERAPEUTICS INC | 1,469,971 | $40M | 5.7% |
| TSEM | TOWER SEMICONDUCTOR LTD | 108,265 | $28M | 4.1% |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,014,606 | $22M | 3.2% |
| BIIB | BIOGEN INC | 96,626 | $21M | 3.0% |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 588,494 | $20M | 2.8% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 328,550 | $19M | 2.7% |
| CYTK | CYTOKINETICS INC | 219,987 | $19M | 2.7% |
| BBIO | BRIDGEBIO PHARMA INC | 245,346 | $18M | 2.6% |
| COGT | COGENT BIOSCIENCES INC | 459,340 | $18M | 2.6% |
Track Sphera Funds Management Ltd's 13F portfolio: $691M in reported holdings, 113 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}